Everyone Medicines

Pharmaceutical company

Based in MA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $290K in lobbying spend across 9 quarterly filings, Everyone Medicines is an active lobbying client. Their lobbying covers 1 issue area. Active from 2024 to 2025.

$290K
Total Spend
2
Years Active
1
Firms Hired
4
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2024$170K
2025$120K

Issues Lobbied

Health Issues

Lobbying Firms

BGR Government Affairs

Lobbyists

Brent Del MonteJohn StoneRyan LongRemy Mason

Government Agencies Targeted

These are the government entities that Everyone Medicines disclosed contacting in their lobbying filings.

Food & Drug Administration (FDA)Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

Provide strategic counsel and advocate on issues related to developing a Food and Drug Administration framework for single-patient products

Provide strategic counsel and advocate on issues related to rare disease drug development

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Akebia Therapeutics, INC.
$9.8M total spend
Ardelyx, INC.
$9.4M total spend
Sumitomo Pharma America, INC. (Formerly Sunovion Pharmaceuticals INC.)
$7.5M total spend
Sage Therapeutics
$4.8M total spend
Organogenesis INC.
$4.0M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.